Here’s an opportunity for all interested stakeholders to get the latest information about priority initiatives and process changes from the CADTH pharmaceutical reviews portfolio.
Thursday, November 26, 2020
9:00am – 12:00pm EST
The session includes an open forum, where attendees can direct questions to CADTH President and CEO Suzanne McGurn and other senior staff at CADTH. Advance registration required.